“…The pathogenesis of Gaucher tumor with PLE remains unclear. It is speculated to be related to mesenteric lymphadenopathy, secondary lymphatic obstruction, inadequate enzyme replacement therapy (ERT) dosage, splenectomy, and the development of neutralizing antibodies against ERT[ 10 , 11 ]. Currently there is no effective and targeted treatment for Gaucher tumor with PLE.…”